X-ray to study micronutrients in human minibrains

It is consensus that mothers’ diet has critical effects on fetal development, and the absence of nutrients is related to impairments on brain formation. In order to characterize the nutrients during human brain development, Brazilian scientists investigated human minibrains using synchrotron radiation, a sort of X-ray. Results showed that concentration and distribution of chemical elements are related to the stage of development and similar to previous data obtained from postmortem brain samples.

Read More...

Comments Off on X-ray to study micronutrients in human minibrains

Epilepsy drug discovered in fish model shows promise in small pediatric clinical trial

‘Bench-to-bedside’ describes research that has progressed from basic science in animal models that has led to therapies used in patients. Now, a study describes what could be considered a direct ‘aquarium-to-bedside’ approach, taking a drug discovered in a genetic zebrafish model of epilepsy and testing it, with promising results, in a small number of children with the disease.

Read More...

Comments Off on Epilepsy drug discovered in fish model shows promise in small pediatric clinical trial

Struggle with Depression? Neuroscience Says This May Reduce Symptoms by 40 Percent

Depression is one of the most common mental health disorders in the United States. It affects over 15 million adults annually, or 6-7 percent of the entire adult population. It is so common, in fact, that nearly everyone has either been affected by it personally or is involved in some way with someone who has/is.Depression has serious costs to both individuals as well as employers. Major Depressive Disorder is the…

Read More…

How Lou Gehrig’s disease progression could be delayed

A team of biomedical scientists has identified a molecule (123C4) that targets a gene (EphA4 receptor) that plays a critical role in the progression of amyotrophic lateral sclerosis, sometimes known as Lou Gehrig’s disease, which affects motor neurons. The expression of EphA4 is associated also with other conditions including abnormal blood clotting, spinal cord and brain injury, Alzheimer’s disease, as well as gastric and pancreatic cancers.

Read More...

Comments Off on How Lou Gehrig’s disease progression could be delayed

The Internet and your brain are more alike than you think

A similar rule governs traffic flow in engineered and biological systems, reports a researcher. An algorithm used for the Internet is also at work in the human brain, says the report, an insight that improves our understanding of engineered and neural networks and potentially even learning disabilities.

Read More...

Comments Off on The Internet and your brain are more alike than you think

New cause of brain defects in tuberous sclerosis complex

A new molecular pathway that inhibits the myelination of neurons in the brains of patients with the rare genetic disorder tuberous sclerosis complex (TSC) has been discovered by researchers. The study suggests new ways to treat some of the neurological symptoms associated with TSC, including autism and epilepsy.

Read More...

Comments Off on New cause of brain defects in tuberous sclerosis complex

Noradrenaline enhances vision through beta-adrenergic receptors

Noradrenaline is a neuromodulator secreted in the brain depending on behavioral context and physiological states of animal, influencing a wide range of physiological functions by modulating brain activity. It may be best known as a hormone to regulate heart rate and blood flow, and many drugs, such as well-known beta blockers, target its effects. It also modulates the visual system.

Read More...

Comments Off on Noradrenaline enhances vision through beta-adrenergic receptors

Anti-cell death agent a potential treatment for vision loss associated with MS

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study.

Read More...

Comments Off on Anti-cell death agent a potential treatment for vision loss associated with MS